div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: · 2019-01-15 · pacientä cu epilepsie intentioneazä sä rämãnä gravidä iar pacientele trebuie consiliate cu privire la riscurile cunoscute Tratamentul cu levetiracetam src=https:reader030vdocumentecomreader030viewer20220403175e5f25ed69d53322361a2538html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: · 2019-01-15 · pacientä cu epilepsie intentioneazä sä rämãnä gravidä iar pacientele trebuie consiliate cu privire la riscurile cunoscute Tratamentul cu levetiracetam src=https:reader030vdocumentecomreader030viewer20220403175e5f25ed69d53322361a2538html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: · 2019-01-15 · pacientä cu epilepsie intentioneazä sä rämãnä gravidä iar pacientele trebuie consiliate cu privire la riscurile cunoscute Tratamentul cu levetiracetam src=https:reader030vdocumentecomreader030viewer20220403175e5f25ed69d53322361a2538html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: · 2019-01-15 · pacientä cu epilepsie intentioneazä sä rämãnä gravidä iar pacientele trebuie consiliate cu privire la riscurile cunoscute Tratamentul cu levetiracetam src=https:reader030vdocumentecomreader030viewer20220403175e5f25ed69d53322361a2538html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: · 2019-01-15 · pacientä cu epilepsie intentioneazä sä rämãnä gravidä iar pacientele trebuie consiliate cu privire la riscurile cunoscute Tratamentul cu levetiracetam src=https:reader030vdocumentecomreader030viewer20220403175e5f25ed69d53322361a2538html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdiv